Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Biotechnology Research
CytoMed Therapeutics Limited is a Biotechnology Research brand in Singapore. Ownership is publicly held; it publishes at cytomed.sg. It holds one address on record, all in Singapore. The record counts 26 people. One Singapore registration (UEN) is a candidate match. It is listed alongside three similar brands, mostly in Biotechnology Research.
UEN201808327H
| CYTOMED THERAPEUTICS LIMITED | UEN 201808327H |
|---|---|
| Confirmed matches | 0 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Incorporated in 2018, CytoMed Therapeutics (NASDAQ: GDTC) was spun off from the Agency for Science, Technology and Research (A*STAR), Singapore’s national research and development agency in the public sector. CytoMed is a biopharmaceutical company focused on harnessing its licensed proprietary technologies to create novel, allogenic off-the-shelf cellular immunotherapies for the treatment of human cancers, both liquid and solid tumors. The development of novel technologies has been inspired by the clinical success of existing CAR-T in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into treatment of solid tumors. The leading CAR-γδ T cell technology, CMT-N2D therapy, is now a clinical trial-ready product set to begin Phase 1 clinical trials.
| Countries | 1 |
|---|---|
| Primary country | SG |
All codes: SG
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Counts only. No names are stored here, and none are served.
One Singapore entity on ACRA. CYTOMED THERAPEUTICS LIMITED (UEN 201808327H), medium confidence.
The record holds 26 counted staff profiles at January 2026, inside the self-reported 11–50 band.
One address on record, Singapore only. Primary: 1 Commonwealth Ln, #08-22, Singapore 149544.
None linked to this brand.
3 profiles list CytoMed Therapeutics Limited as a peer — 49th percentile in Biotechnology Research. It lists ten peers of its own. Singzyme lists it back.